# Methotrexate in Erosive Inflammatory Hand Osteoarthritis

> **NCT04579848** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Diakonhjemmet Hospital** · enrollment: 163 (estimated)

## Conditions studied

- Hand Osteoarthritis
- Erosive Osteoarthritis

## Interventions

- **DRUG:** Methotrexate Tablets
- **DRUG:** Placebo
- **DRUG:** Folic Acid 1 MG

## Key facts

- **NCT ID:** NCT04579848
- **Lead sponsor:** Diakonhjemmet Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-08-12
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 163 (ESTIMATED)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04579848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04579848, "Methotrexate in Erosive Inflammatory Hand Osteoarthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04579848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*